Log In
Print
BCIQ
Print
Print this Print this
 

dalbavancin (Dalvance) (RQ-00000002)

Also known as: formerly Exulett, Zeven

  Manage Alerts
Collapse Summary General Information
Company Durata Therapeutics Inc.
DescriptionSecond-generation glycopeptide antibiotic
Molecular Target D-alanyl-D-alanine
Mechanism of ActionCell wall synthesis inhibitor
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today